Adjuvant Hepatic Arterial Infusional Chemotherapy with 5-Fluorouracil and Cisplatin after Curative Resection of Hepatocellular Carcinoma

Publisher： Karger

E-ISSN： 1423-0232|81|3-4|184-191

ISSN： 0030-2414

Source： Oncology, Vol.81, Iss.3-4, 2011-11, pp. : 184-191

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hepatic Arterial Infusion Chemotherapy Using Low-Dose 5-Fluorouracil and Cisplatin for Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 78, Iss. 1, 2010-07 ,pp. : 148-153

Karger

Access to resources Recommend Favorite

Beneficial Effects of 5-Fluorouracil and Heparin-Based Portal Infusion Chemotherapy Combined with Mitomycin C and Cisplatin after Curative Resection of Pancreatic Cancer

By  

Pancreatology, Vol. 10, Iss. 2-3, 2010-05 ,pp. : 250-258

Karger

Access to resources Recommend Favorite

Clinical Pilot Study of Intrahepatic Arterial Chemotherapy with Methotrexate, 5-Fluorouracil, Cisplatin and Subcutaneous Interferon-Alpha-2b for Patients with Locally Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 55, Iss. 1, 1997-12 ,pp. : 39-47

Karger

Access to resources Recommend Favorite

Is There a Role for Adjuvant Treatment after Hepatic Resection for Hepatocellular Carcinoma?

By  

Oncology, Vol. 78, Iss. 3-4, 2010-06 ,pp. : 161-171

Karger

Access to resources Recommend Favorite

Neutrophil/lymphocyte ratio as a prognostic indicator of hepatic arterial infusion chemotherapy with arterial cisplatin plus continuous 5‐fluorouracil

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 7, 2015-07 ,pp. : 755-763

John Wiley & Sons Inc

Access to resources Recommend Favorite